@xconomy.com 1 month ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 1 month ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 1 month ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 2 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@marcusborba 2 months ago
Multimodal Depression Severity Prediction from medical bio-markers using #MachineLearning Tools and Technologies. #BigData #Analytics #RStats #Python #JavaScript #ReactJS #Serverless #IoT #Linux #100DaysofCode #Programming #DataScience #DeepLearning #AI https://arxiv.org/abs/2009.05651 https://t.co/sEhdIXpzVv
@xconomy.com 2 months ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com 4 months ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@The_RDMLA 6 months ago
Hey learners - if you're looking for more #rdm, #datamanagement & #DataScience learning opportunities, check out @jgolds2's Bio-Medical RDM class (https://bit.ly/2YWBp5j), @thecarpentries, @DataONEorg, and @harvardx has some free classes (https://bit.ly/3cpQBvC) too! #datalibs
@xconomy.com 7 months ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com 8 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 9 months ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 9 months ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@engadget.com 10 months ago
Feles wants to build all-in-one bio labs for the intensely curious
@rene_ziegler 10 months ago
Dr. #AI – ⁦@BoschGlobal⁩ facilitates medical diagnosis with #artificialintelligence. Edge-computing #machinelearning algorithms detect abnormalities in bio samples and thus support faster diagnosis and treatment. #BoschCES #HealthTech https://www.bosch-presse.de/pressportal/de/en/dr-ai-%E2%80%93-bosch-facilitates-medical-diagnosis-with-artificial-intelligence-205287.html#__prclt=ctnH8WiC
@xconomy.com 1 year ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 1 year ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com 1 year ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com 1 year ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 1 year ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com 1 year ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com 1 year ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 1 year ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com 1 year ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com 1 year ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com 1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com 1 year ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com 1 year ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@IainLJBrown 1 year ago
Artificial Intelligence In Precision Medicine And Drug Discovery: Insights From The Recent Annual 18th Bio-IT World Conference - Seeking Alpha Read more here: http://bit.ly/2W4fCnX #ArtificialIntelligence #AI #DataScience #MachineLearning #BigData #DeepLearning #NLP #Robots…
@xconomy.com 1 year ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com 1 year ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com 1 year ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com 1 year ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com 1 year ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 1 year ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com 1 year ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com 1 year ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com 1 year ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 1 year ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com 1 year ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com 2 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com 2 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com 2 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 2 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com 2 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com 2 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@LuminateHealth 4 years ago
In applying #machinelearning to #humanbiology, one approach: cancer, other bio processes are info processing systems http://bit.ly/2eHjnue
@thenextweb.com 4 years ago
Chan Zuckerberg initiative pledges $3B to wipe out disease